Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 2/20 | 0.54 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | MITF | O75030 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12449349 | 1.00 | CYP19A1 (0.54) | CYP19A1EPHX1ALDH1A1NPSR1TSHR | |
| SCHEMBL21868824 | 1.00 | CYP19A1 (0.54) | CYP19A1EPHX1ALDH1A1NPSR1TSHR | |
| SCHEMBL30252989 | 1.00 | CYP19A1 (0.54) | CYP19A1EPHX1ALDH1A1NPSR1TSHR | |
| SCHEMBL12449333 | 1.00 | CYP19A1 (0.54) | CYP19A1EPHX1ALDH1A1NPSR1TSHR | |
| Succinic Acid SCHEMBL28887680 | 0.99 | CYP19A1 (0.53) | CYP19A1EPHX1ALDH1A1NPSR1TSHR | |
| SCHEMBL29748715 | 0.97 | CYP19A1 (0.52) | CYP19A1EPHX1ALDH1A1NPSR1TSHR | |
| SCHEMBL6285388 | 0.97 | CYP19A1 (0.54) | CYP19A1EPHX1ALDH1A1NPSR1TSHR | |
| Glutarate SCHEMBL28887678 | 0.97 | CYP19A1 (0.54) | CYP19A1EPHX1ALDH1A1NPSR1TSHR | |
| SCHEMBL14449966 | 0.97 | CYP19A1 (0.54) | CYP19A1EPHX1ALDH1A1NPSR1TSHR | |
| SCHEMBL28249516 | 0.96 | CYP19A1 (0.51) | CYP19A1EPHX1ALDH1A1NPSR1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1752 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260103459-A1 | SUBSTITUTED AZACYLES AS TRPM8 MODULATORS | GIVAUDAN SA (CH) | 2026-04-16 | — | — | US | claimed |
| US-12564552-B2 | Oral product with a basic amine and an ion pairing agent | Nicoventures Trading Limited (GB) | 2026-03-03 | — | — | US | claimed |
| EP-4687504-A1 | ORAL COMPOSITIONS AND METHODS OF MANUFACTURE | Nicoventures Trading Limited (GB) | 2026-02-11 | — | — | EP | claimed |
| EP-4687502-A1 | STARCHLESS MOLDING PROCESS FOR ORAL PRODUCTS | Nicoventures Trading Limited (GB) | 2026-02-11 | — | — | EP | claimed |
| EP-4691492-A2 | LIQUID COMPOSITIONS | Kenvue Brands LLC (US) | 2026-02-11 | — | — | EP | claimed |
| EP-3817575-B1 | SOLUBILISATION OF COOLING AGENTS OF LOW SOLUBILITY | SYMRISE AG (DE) | 2025-10-15 | — | — | EP | claimed |
| EP-3908266-B1 | LIQUID COMPOSITIONS | KENVUE BRANDS LLC (US) | 2025-10-15 | — | — | EP | claimed |
| CN-120129464-A | Flavonoid compound and application thereof | 弗门尼舍有限公司 | 2025-06-10 | — | — | CN | claimed |
| US-20250154123-A1 | COOLING COMPOUNDS AND COMPOSITIONS | V MANE FILS (FR) | 2025-05-15 | — | — | US | claimed |
| CN-114555594-B | Substituted azacycles as TRMP modulators | 奇华顿股份有限公司 | 2025-03-18 | — | — | CN | claimed |
| EP-1446019-A1 | WATER CONTINUOUS FOOD PRODUCT WITH COOLING FLAVOUR | UNILEVER N.V. (NL) | 2004-08-18 | — | — | EP | claimed |
| US-20040141927-A1 | Chewing gums, confections, mouthwashes, mouth sprays and edible thin film products | WM. WRIGLEY JR. COMPANY | 2004-07-22 | — | — | US | claimed |
| WO-2004045590-A1 | ORAL PRODUCTS CONTAINING NOVEL FLAVOR COMPOSITION | WM. WRIGLEY JR. COMPANY (US) | 2004-06-03 | — | — | WO | claimed |
| WO-2004019922-A1 | BREATH FRESHENING AND ORAL CLEANSING PRODUCT USING CITRAL | WM. WRIGLEY JR. COMPANY (US) | 2004-03-11 | — | — | WO | claimed |
| WO-2004019800-A2 | BREATH FRESHENING AND ORAL CLEANSING PRODUCT | WM. WRIGLEY JR. COMPANY (US) | 2004-03-11 | — | — | WO | claimed |
| WO-2004019870-A2 | BREATH FRESHENING AND ORAL CLEANSING PRODUCT USING SALICYLALDEHYDE | WM. WRIGLEY JR. COMPANY (US) | 2004-03-11 | — | — | WO | claimed |
| WO-2004019867-A2 | BREATH FRESHENING AND ORAL CLEANSING PRODUCT USING CARDAMOM OIL | WM. WRIGLEY JR. COMPANY (US) | 2004-03-11 | — | — | WO | claimed |
| WO-2004019802-A2 | BREATH FRESHENING AND ORAL CLEANSING PRODUCT USING CARVACROL | WM. WRIGLEY JR. COMPANY (US) | 2004-03-11 | — | — | WO | claimed |
| WO-2004019871-A2 | BREATH FRESHENING AND ORAL CLEANSING PRODUCT USING GERANIOL | WM. WRIGLEY JR. COMPANY (US) | 2004-03-11 | — | — | WO | claimed |
| WO-2003043431-A1 | WATER CONTINUOUS FOOD PRODUCT WITH COOLING FLAVOUR | UNILEVER N.V. (NL) | 2003-05-30 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260103459-A1 | SUBSTITUTED AZACYLES AS TRPM8 MODULATORS | TRPM8, TRPM7, TRPM5 | CYP19A1 2198/4885EPHX1 4381/4885ALDH1A1 1111/4885 |
| US-12564552-B2 | Oral product with a basic amine and an ion pairing agent | SLC25A11, SLC16A7, SDHB | CYP19A1 1186/4885EPHX1 802/4885ALDH1A1 524/4885 |
| US-20250154123-A1 | COOLING COMPOUNDS AND COMPOSITIONS | CBR3, DECR1, DECR2 | CYP19A1 148/4885EPHX1 479/4885ALDH1A1 1426/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.